Intralipid

Soybean oil, the active ingredient in Intralipid, is a parenteral nutrition lipid emulsion presented as an emulsion for intravenous infusion. It provides calories and essential fatty acids to patients who cannot receive enteral feeding, helping to prevent or treat essential fatty acid deficiency.

GNH USA supplies Intralipid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres and pharmacies worldwide. The company ensures quality compliance with EU standards and provides cold‑chain logistics where required.

Intralipid is used in parenteral nutrition to supply essential lipids and calories for patients unable to tolerate enteral feeding. - Patients requiring parenteral nutrition: supplies calories and essential fatty acids when enteral feeding is not possible. - Essential fatty acid deficiency: prevents or treats deficiency in long‑term parenteral nutrition. - Critical illness or surgery: provides an energy source during periods of high metabolic demand.

Adverse reactions to Intralipid may vary in frequency and severity.

Common Side Effects: - Elevated triglycerides: transient increase in serum triglyceride levels. - Fever or chills: mild infusion‑related pyrexia. - Nausea: occasional gastrointestinal upset.

Serious or Rare Side Effects: - Anaphylaxis: severe hypersensitivity reaction requiring immediate medical intervention. - Acute respiratory distress syndrome (ARDS): rare pulmonary complication. - Liver dysfunction: abnormal liver enzymes in susceptible patients.

When using Intralipid, clinicians should observe several safety measures. - Patient assessment: evaluate baseline triglyceride levels and liver function before initiating therapy. - Infusion rate: administer according to prescribed rate to minimize risk of hypertriglyceridemia. - Compatibility: verify compatibility with other intravenous solutions; avoid mixing with calcium‑containing solutions. - Monitoring: regularly monitor serum triglycerides, liver enzymes, and respiratory status during treatment. - Contraindications: do not use in patients with known hypersensitivity to soy or egg products. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Intralipid can interact with other medications, requiring careful review.

Major Interactions (Avoid): - Heparin: may potentiate hypertriglyceridemia. - Cytotoxic chemotherapy: increased risk of lipid overload. - Propofol: additive lipid load leading to severe hypertriglyceridemia.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of INR due to lipid interference. - Beta‑blockers: may affect lipid metabolism. - Lipid‑lowering agents (e.g., fibrates): monitor triglyceride levels.